Home › Funds › Arrowstreet Capital › HAE

Arrowstreet Capital position in HAE

HAEMONETICS CORP MASS · Health Care

Latest position (Q2 2026)1.16M sh
Reported value held$86.65M
Portfolio Weight0.04%
First reportedQ2 2022
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q2 2022 33.68K $2.19M New
Q3 2022 172.86K $12.80M Add
Q4 2022 627.32K $49.34K Add
Q1 2023 661.05K $54.70K Add
Q2 2023 671.18K $57.15K Add
Q3 2023 235.20K $21.07K Reduce
Q4 2023 158.02K $13.51K Reduce
Q1 2024 167.50K $14.30K Add
Q2 2024 110.11K $9.11K Reduce
Q3 2025 126.07K $6.14M New
Q4 2025 1.38M $110.62M Add
Q1 2026 1.38M $77.95M Hold
Q2 2026 1.16M $86.65M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding HAE

All HAE fund holders →